Rose McNulty

An innovative artificial intelligence (AI) tool enhanced alopecia areata assessment and improved treatment adherence.

Allergen immunotherapy was associated with reduced medication use and improved asthma control for up to 9 years.

Online racial discrimination, bias, and trauma are linked to anxiety and depression in Black adolescents.

AstraZeneca has struck a deal with the Trump administration to sell lower-priced drugs via TrumpRx, following a similar agreement with Pfizer.

Explore the implications of the Most Favored Nation Order on US drug pricing reform and its potential impact on patient access and innovation.

David Rometo, MD, reflects on the sustainability of incremental weight loss programs and aggressive diets.

Telemedicine improved the quality of life and inhaler technique among patients with advanced-stage chronic obstructive pulmonary disease (COPD).

Researchers developed a first-of-its-kind panel to track receptor expression and predict therapy response.

The study highlighted pain, fatigue, and functional status as key early warning signs.

Nanopore sequencing of chronic lymphocytic leukemia (CLL) may be a particularly good fit in under-resourced areas due to its lower cost and smaller laboratory footprint.

Early research has identified several antigens that could help facilitate the use of chimeric antigen receptor T cells in small cell lung cancer.

Social determinants of health disproportionately impact patients' ability to maintain and achieve their weight loss goals.

Emotional well-being and social engagement significantly impact quality of life for patients with soft tissue sarcoma post-surgery.

The class of diabetes drug has a protective effect on the kidneys for reasons beyond glucose control.

Funding cuts for research intended to make treatment and cures available and accessible for patients with HIV could affect HIV care in the long term.

Empathy and communication strengthen patient-provider relationships and improve respiratory care outcomes, as discussed at the European Respiratory Society (ERS) Congress.

David Rometo, MD, weighs various weight loss treatments, their success, and sustainability.

New treatment options are needed for patients with accelerated-phase or blast-phase myeloproliferative neoplasms (MPNs) ineligible for standard care.

The approval is the first in more than a decade for an idiopathic pulmonary fibrosis treatment.

David Rometo, MD, of UPMC, addresses stigma surrounding obesity and group setting weight loss intervention therapies and how consults benefit patients.

Weight loss medications show promise in improving liver health for those with chronic liver conditions, a review found.

Aumolertinib was compared against osimertinib to demonstrate its efficacy in those with mutated non-small cell lung cancer (NSCLC).

Rilzabrutinib (Wayrilz; Sanofi) may improve immune thrombocytopenia (ITP) outcomes, enable early intervention, and enhance patient quality of life.

Adverse events related to the immune system tended to accumulate over time when patients used immune checkpoint inhibitors (ICIs) over time.

Although overall costs have not declined with the Oncology Care Model (OCM), supportive care costs have decreased through greater use of cost-effective therapies.

An eHealth survey revealed widespread confusion, low awareness of 2026 Medicare plan changes, and growing interest in artificial intelligence support.

Vivek Subbiah, MD, considers artificial intelligence (AI) and comprehensive somatic and germline testing essential for guiding precision oncology and improving patient care.

UC Davis pharmacy residents research medication management and patient care, focusing on how pharmacists improve outcomes and reduce readmissions, according to Jeremiah J. Duby, PharmD, BCPS, BCCCP.

The Trump administration advances the Most Favored Nation order by partnering with Pfizer, which came to the table voluntarily and has been granted a reprieve from upcoming drug tariffs.

Biomarkers like neutrophil-to-lymphocyte ratio could help predict treatment response to immune checkpoint inhibitors in certain patients with soft tissue sarcoma.